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Abstract
Background and Objective: Sulfonamides are known to represent a class of medicinally important compounds and chemical
intermediates,  which  are  extensively  used in drug development. The aim of this present study is to synthesize a series of
arylsulfonamide-based dialkylated amide motifs. Materials and Methods: In this study, the design and development of arylsulfonamide
pharmacophore bearing N,N-diethyl substituted amide moieties 2a-k was achieved in improved yields using non-conventional amidation
of p-tolylsulfonamide precursors 1a-k. The structures of the compounds were substantiated based on the results of elemental analysis
and spectroscopic data namely, FT-IR, 1H-NMR, 13C-NMR and mass spectra. Results: The series of targeted compounds were synthesized
in good to excellent yields and subsequently purified by column chromatography where necessary. Conclusion: The synthesis of
arylsulfonamide-based dialkylated amide motifs was successfully achieved. These compounds may serve as versatile intermediates that
pave ways toward achieving diverse bioactive heterocyclic compounds for future drug discovery and development.
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INTRODUCTION
In  primary care medicine, sulfonamides are widely used
in various conditions including gastrointestinal1 and urinary
tract infections2. In fact, sulfonamide which is the organic
framework   of   main   focus   in   this   present   study   belongs 
to the family of sulfur-containing compounds with -SO2NH-
functionality which are earlier referred as to as the sulfa drugs3.
The characterization of sulfonamides as chemotherapeutics is
more than half a century old4. Since, then, the sulfonamide
group has been found as a key structural motif shared by a
large number of bioactive compounds5-7. In view of this,
consistent  exploration of sulfonamide chemistry has led to
the development of highly versatile probes with a broad range
of applications, some of, which include activatable
photosensitizers8, chemosensors with selective fluorescence
enhancement among others9. Sulfonamide containing
moieties are reported to be self-assembled into robust two
dimensional molecular layers10 as well as being valuable
building block for higher order superstructures11.
Furthermore,  due  to  high  industrial  relevance  and
wide   applications,   a   variety   of   protocols   were   available
for  the  synthesis  of  sulfonamide.  Among  the  various
methods reported, it is obvious that the most convenient and
efficient ways involved the reaction of sulfonyl chloride
derivatives with nucleophilic amino containing templates,
such   as   1-naphthylmethyl   amine12,   substituted aniline13,
piperidine14,   ethanamine15,   benzo[d]thiazol-2-amine16,
dimethyl   2-aminopentanedioate17,   8-aminoquinoline18,
cyclohexanamine19, diprotected glutamic acid20, pyrrole21 and
morpholine22 to afford the respective sulfonamide products.
Many derivatives of sulfonamide have been explored as
important starting materials and reactive intermediates in
various   organic   syntheses23-25.   This  authenticates  their
well-established utility in the synthesis of pyrrolidines26,
isothiourea27, secondary amine28, superacid mediated
reaction29, enantioselective reduction of "-ketoester30 and
monoalkylation of amino group31. It has also proved to be vital
precursor in the total synthesis of some natural product, such
as (-)-cylindricine32, lepadiformine33, fasicularin34 and natural-
product-like molecules35.
In a similar manner, amide formation is a fundamental
reaction of great interest in organic chemistry36. The
development of efficient methods for the synthesis of amides
remains an excellent idea because of their importance in
chemistry and biology, with a wide range of industrial and
pharmaceutical applications and as valuable intermediates in
organic synthesis37. Hence, it is conceivable to design the
synthetic  route in  this  present study  in  such  a  way  to  have
amide functionality being incorporated within the framework
of the synthesized sulfonamides. This might probably lead to
discovery of compounds with increase biological activity for
future drug design and also help in the comparative study of
pharmacological properties of the ordinary sulfonamide to
that of amide-bearing sulfonamide derivatives.
MATERIALS AND METHODS
General condition: The melting points were determined on
XT-4 Digital Binocular Microscope melting point apparatus
and were uncorrected. The IR spectra were run on Varian
Excalibur HE 3100 FT-IR Spectrometer while the Mass Spectra
were obtained using Waters GCT Premier Spectrometer. The
1H-NMR spectra were recorded in either CDCl3 or DMSO-d6 on
NMR Bruker DP×400 spectrometer operating at 400 MHz.
Tetramethyl silane (TMS) was used as internal standard with
the  deuterium  signal  of  the  solvent  as the  lock  and
chemical shifts * recorded in ppm.  The   elemental   analysis
(C, H and N)   of  the  compounds  were  performed  using 
Flash EA 1112 Elemental Analyzer. The pH was monitored
using Portable pH Meter Model PHB4. All drying was
conducted at reduced pressure with DHG-9023A  Vacuum
Oven. In addition, column chromatographic purifications were
carried out on the products using CHCl3/CH3OH (9:1) solvent
system and Merck silica gel F (Mesh 200-300). Organic
solutions were dried over anhydrous Na2SO4 and concentrated
with a RE-2000B Buchi Rotary Evaporator. Commercially
available materials were used without further purification,
while other reagents were used directly after ascertaining the
purity condition.
General procedure for p-toluenesulfonamide (1a-k): To a
solution   of   amino   acid  (12.5   mmol)   in   water   (15   mL)
was  added   Na2CO3   (2.785   g,   26.25   mmol)   at   0EC   and
p-toluenesulfonyl chloride, p-TsCl (2.86 g, 15 mmol) in 3
portions over a period of 1 h. The slurry was then warmed to
room temperature and allowed to stir for 48 h. Upon
completion of the reaction, which was TLC monitored using
CHCl3/CH3OH solvent system (9:1), the reaction mixture was
acidified with 20%  concentrated  aqueous  HCl  solution  to
pH 2, after which crystallization occurred and the product was
obtained via suction filtration. The filtered crude product was
washed  with pH 2.2 buffer and dried in a vacuum oven at
60EC for 12 h to afford p-toluenesulfonamides (1a-k).
1-(4-methylphenylsulfonamido) pyrrolidine-2-carboxylic
acid  (1a):  The  IR:  3217  (OH),  2939  (CH   aliphatic),   2860
(CH arom.), 1734 (C=O of COOH), 1601 (C=C arom.),  1152,
1094  (SO2     two    bands),   662   (Ar-H).    1H-NMR   (400   MHz,
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DMSO-d6): 7.72-7.70 (d, J = 8.0, 2H, Ar-H), 7.43-7.41 (d, J = 8.0,
2H,  Ar-H),  4.08-4.05  (m,  1H),  3.36-3.30  (m,  1H),  3.16-3.10
(m, 1H), 2.39 (s, 3H, CH3), 1.86-1.76 (m, 3H), 1.58-1.49 (m, 1H).
13C-NMR (400 MHz, DMSO-d6): 173.2 (C=O), 143.5, 134.7, 129.9, 
127.2,  67.1,  60.5, 48.5,  30.5,  25.2,  24.3  and  21.1.  The EI-MS
(% rel.): 269.1 (M+, 11), 179.1 (21), 178.1 (100), 176.1 (34), 122.0
(49) and 105 (32).
1-(4-methylphenylsulfonamido) piperidine-2-carboxylic
acid (1b): The 1H-NMR (400 MHz, CDCl3): 7.70-7.68 (d, J = 8.0
Hz, 2H, Ar-H), 7.28-7.26 (d, J = 8.0 Hz, 2H, Ar-H), 4.74-4.73 (m, 
1H), 3.72-3.69 (d, J = 12.0 Hz, 1H), 3.23-3.17 (t, J = 12.0 Hz, 1H),
2.41 (s, 3H, CH3-Ar), 2.18-2.15  (m,  1H),  1.67-1.55  (m,  3H),
1.45-1.31 (m, 2H). 13C-NMR (400 MHz, DMSO-d6): 171.6 (C=O),
142.9, 137.4, 129.6 (2×CH arom.), 126.8 (2×CH arom.), 54.6,
42.1, 27.0,   23.9,   21.0   (CH3),   19.7   (CH2).   EI-MS   (%   rel.):  
239.1 (M+-CO2, 10), 238.1 (74), 220.1 (37), 191.1 (28), 91.1 (100).
2-(4-methylphenylsulfonamido) acetic acid (1c): The IR: 3279
(N-H), 3102 (OH), 2980 (CH aliphatic), 1726 (C=O of COOH),
1595 (C=C aromatic), 1234, 1161 (SO2 two bands), 669 (Ar-H).
1H-NMR  (400  MHz,  DMSO-d6):  12.63   (s-br,   1H),   7.95-7.92
(t, J = 6.0 Hz, 1H), 7.68-7.66 (d, J = 8.0 Hz, 2H, Ar-H), 7.38-7.36
(d, J = 8.0 Hz, 2H, Ar-H),  3.55-3.53  (d,  J  =  6.0  Hz,  2H),  2.37
(s, 3H). EI-MS (% rel.): 238.1 (41), 184.0 (55), 155.0 (100), 91.1
(65), 65.0 (63), 44.0 (39).
2-(4-methylphenylsulfonamido) propanoic  acid  (1d):  The
IR: 3277 (N-H), 3084 (OH), 2934 (CH aliphatic), 1715 (C=O of
COOH), 1649 (C=C aromatic), 1233 1150 (SO2  two  bands), 677
(Ar-H). 1H-NMR (400 MHz, DMSO-d6): 8.05-8.03 (d, J = 8.3 Hz,
1H), 7.67-7.65 (d, J = 8.0 Hz, 2H, Ar-H), 7.37-7.35 (d, J = 8.0 Hz,
2H, Ar-H), 3.74-3.71 (m, 1H), 2.37 (s, 3H), 1.13-1.12 (d, J = 7.2 Hz,
3H). EI-MS (% rel.): 199.1 (M+-CO2, 12), 198.0 (89), 156.0 (21),
155.0 (98), 91.1 (100), 65.0 (47), 44.1 (27).
3-mercapto-2-(4-methylphenylsulfonamido) propanoic acid
(1e): The IR: 3445 (N-H), 3003 (OH), 2907 (CH aliphatic), 1736
(C=O of COOH), 1596 (C=C aromatic), 1221, 1152 (SO2 two
bands),  679  (Ar-H).  1H-NMR  (400 MHz, DMSO-d6): 8.59-8.53
(s-br,   1H),  7.81-7.79  (d,  J   =   8.0  Hz,  2H,  Ar-H),  7.28-7.26 
(d, J = 8.0 Hz, 2H, Ar-H), 5.83-5.81 (d, J = 8.4 Hz, 1H), 3.81-.3.78
(m, 1H), 3.10-3.08 (d, J = 7.63 Hz, 2H), 2.37 (s, 3H).
2-(4-methylphenylsulfonamido)-4-(methylthio) butanoic
acid   (1f):   The   IR:  3566  (N-H),  2982 (CH  aliphatic),  2874
(CH aromatic), 1740 (C=O), CH3-S (1653), 1609 (C=C), 1148,
1109 (SO2  two  bands),  671  (Ar-H).  1H-NMR  (400  MHz, 
CDCl3): 7.75-7.73 (d, J = 8.0 Hz, 2H, Ar-H), 7.29-7.27 (d, J = 8.0
Hz, 2H, Ar-H), 5.75 (s-br, 1H), 4.07 (s-br, 1H), 3.25 (s-br, 2H),
2.50-2.48 (m, 1H), 2.40 (s, 3H), 1.99 (s, 3H), 1.95-1.89 (m, 1H).
3-methyl-2-(4-methylphenylsulfonamido) butanoic acid
(1g): The IR: 3289 (N-H), 2967 (CH aliphatic), 1711 (C=O of
COOH), 1595 (C=C aromatic), 1335, 1163 (SO2  two  bands),
687 (Ar-H). 1H-NMR (400 MHz, CDCl3): 7.73-7.71 (d, J = 8.0 Hz,
2H,  Ar-H),  7.29-7.27  (d,  J   =   8.0  Hz,   2H,  Ar-H),   5.07-5.04
(d, J  =  9.9 Hz, 1H), 3.82-3.78 (dd, J1 = 4.6 Hz, J2 = 9.9 Hz, 1H),
2.43 (s, 3H), 2.11-2.08  (m,  1H),  0.97-0.96  (d,  J  =  6.8  Hz,  3H), 
0.88-0.86 (d, J = 6.8 Hz, 3H). EI-MS (% rel.): 270.1 (M+-H, 23),
227.1 (11), 226.1 (100), 155.0 (98), 92.1 (33), 91.1 (92), 65.0 (48).
3-hydroxy-2-(4-methylphenylsulfonamido) butanoic acid
(1h): The IR: 3501 (OH free), 3435 (N-H), 3360 (OH of COOH),
3262 (N-H), 2976 (CH aliphatic), 1697 (C=O), 1595 (C=C
aromatic),  1273,  1167  (SO2  two  bands),  673   (Ar-H).   The
1H-NMR (400  MHz,  DMSO-d6):  7.68-7.66  (d,  J  =  8.0  Hz,  2H, 
Ar-H), 7.54-7.50  (d, J = 9.2, 1H), 7.34-7.32 (d, J  =  8.0  Hz,  2H
Ar-H), 3.98-3.92 (m, 1H), 3.64-3.61 (dd, J1 = 3.6 Hz, J2 = 9.2 Hz,
1H), 2.36 (s, 3H,), 2.08 (s, 1H), 1.01-0.99 (d, J = 6.36 Hz, 3H).
5-amino-2-(4-methylphenylsulfonamido)-5-oxopentanoic
acid (1i): The IR: 3456 (N-H), 3331 (OH of COOH), 3246 (N-H),
2955 (CH aliphatic), 1678 (C=O), 1640 (C=O), 1570 (C=C
aromatic), 1167, 1094 (SO2 two bands), 685 (Ar-H). 1H-NMR
(400 MHz, DMSO-d6): 8.06-8.04 (d, J = 8.8  Hz,  1H),  7.65-7.63
(d, J = 8.0 Hz, 2H, Ar-H), 7.36-7.34 (d, J = 8.0 Hz, 2H, Ar-H), 7.24
(s-br, 1H), 6.74 (s-br, 1H), 3.69-3.65 (ddd, J1 = 3.08 Hz, J2 = 5.52
Hz,  J3 = 8.8 Hz, 1H), 2.37 (s, 3H, CH3-Ar), 2.08-2.06 (t, J = 7.68
Hz, 2H), 1.85-1.79 (m, 1H), 1.67-1.61 (m, 1H). EI-MS: m/z (% rel.):
246.0 (97), 238.1 (16), 171.0 (49), 156.0 (84), 139.0 (52), 123.0
(100), 92.1 (38), 77.0 (41), 44.0 (32).
2-(4-methylphenylsulfonamido)-3-phenylpropanoic acid
(1j): The IR: 3350 (N-H), 3188 (OH), 2961 (CH aliphatic),  1736
(C=O of COOH), 1350, 1171, 1092 (SO2 two bands), 675 (Ar-H).
1H-NMR (400 MHz, CDCl3): 7.61-7.59 (d, J = 8.0 Hz, 2H, Ar-H),
7.24-7.21  (m,  5H,  Ar-H),  7.10-7.08  (m, 2H,  Ar-H),  5.16-5.13
(d, J = 8.64 Hz, 1H), 4.21-4.17 (ddd, J1 =  5.6  Hz,  J2  =  6.4  Hz,
J3 = 8.64 Hz, 1H), 3.12-3.08 (dd, J1 = 5.6 Hz, J2 = 20.0 Hz, 1H),
3.03-2.98 (dd, J1 = 6.4 Hz, J2 = 20.0 Hz, 1H), 2.40 (s,  3H).  The
13C-NMR (100 MHz, CDCl3): 174.9 (C=O), 143.9, 136.6, 134.9,
129.8 (2×CH arom.), 129.6 (2×CH arom.), 128.8 (2×CH arom.),
127.4 (2×CH arom.), 127.2, 56.5, 39.0 (CH2), 21.7 (CH3).
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2-(4-methylphenylsulfonamido)-3-(4-(tosyloxy)phenyl)
propanoic acid (1k): The IR: 3561 (N-H), 3339 (OH of COOH),
2924 (CH aliphatic), 1717 (C=O), 1559 (C=C arom.), 1150, 1092
(SO2 two bands), 669 (Ar-H). The 1H-NMR (400 MHz, CDCl3):
7.69-7.67 (d, J = 8.26 Hz, 2H, Ar-H), 7.59-7.57 (d, J = 8.26  Hz,
2H,  Ar-H),  7.32-7.30  (d,  J  =  8.0   Hz,   2H,   Ar-H),   7.24-7.22
(d, J = 8.0 Hz, 2H, Ar-H), 7.03-7.01 (d, J = 8.4 Hz,  2H,  Ar-H),
6.85-6.83 (d, J = 8.4 Hz, 2H, Ar-H), 5.14-5.12 (d, J = 8.48 Hz, 1H),
4.17-4.12 (q, J = 6.8 Hz, 1H), 3.11-3.06 (dd, J1 = 5.2 Hz, J2 = 20.0
Hz, 1H), 2.97-2.92 (dd, J1 = 6.8 Hz, J2 = 20.0 Hz, 1H), 2.45 (s, 3H),
2.41 (s, 3H). 13C-NMR (100 MHz, CDCl3): 173.7 (C=O), 149.1,
145.8, 144.1, 136.4, 134.1, 132.2 (six benzylic arom.  C),  130.9
(2×CH arom.), 130.0 (2×CH arom.), 129.9 (2×CH arom.), 128.6
(2×CH arom.), 127.2 (2×CH arom.), 122.6 (2×CH arom.), 56.4
(CH), 38.3 (benzylic CH2), 21.9 (CH3 linked to OSO2-Ar), 21.7
(CH3 linked to SO2-Ar). EI-MS: m/z (% rel.): 443.1 (23), 171.0 (35),
156.0 (58), 155.0 (90), 134.1 (90), 92.1 (64), 65.0 (100).
General procedure for synthesis of amidated sulfonamides
(2a-k): A three-necked 250 mL flask equipped with magnetic
stirring bar was charged with appropriate p-toluene
sulfonamide 1a-k (2.96 mmol) and  dichloromethane,  DCM
(10 mL). The flask was closed, cooled to 0EC and nitrogen was
bubbled  into  it  continuously.  Oxalyl  chloride   (0.34  mL,
3.85 mmol, 1.3 equiv.) was cautionly added via dropping
pipette to maintain the temperature below 10EC followed by
the addition of 2 drops of DMF. The resulting mixture was
stirred at room temperature until the conversion to acid
chloride was completed (i.e., for about 1.5 h) and then
concentrated   to   dryness   with   rotary   evaporator   (23EC,
40  mmHg). To the resulting crude acid chloride was added
DCM (20 mL) and the solution was concentrated again. In a
separate 250 mL three-necked round bottom flask, equipped
with  a  magnetic  stirring bar,  a  N2  inlet,  a  rubber  septum,
125 mL pressure equalizing addition funnel and a temperature
probe was charged DCM (10 mL), triethyl amine  (0.62  mL,
4.44 mmol, 1.5 equiv.) and diethyl amine (0.4 mL, 3.85 mmol,
1.3 equiv.) and the mixture was cooled to -10EC.
The crude acid chloride was dissolved in DCM (10 mL) and
this solution was transferred to the addition funnel. The acid
chloride was then added drop-wisely to the stirred diethyl
amine solution at such a rate that the internal temperature
was maintained below 10EC. Upon completion of the addition
of the acid chloride solution (ca 30 min), the mixture was
stirred at -10 to 0EC for 1 h and at room temperature for 1 h.
The mixture was then diluted with 2N HCl (6 mL) and was
transferred  into  a  250  mL  separatory  funnel   and   the
layers  separated.  The  organic layer  was  washed  with  brine
(6 mL) and  was   then  concentrated  under  reduced  pressure 
(23EC,   40   mmHg),   diluted   with   methanol   (6   mL)   and
re-concentrated to give a crude solid. The solid was slurried in
methanol (7.5 mL) and water (15 mL) was added drop-wisely
with continuous stirring for 10 min. The slurry was stirred at
room temperature for 1 h and allowed to crystallize. It was
filtered by suction and dried under vacuum/N2 sweep for 8 h
to afford required N,N-diethyl substituted p-tolylsulfonamides
(2a-k).
N,N-diethyl-1-tosylpyrrolidine-2-carboxamide   (2a):    The
IR: 2976 (CH aromatic), 2872 (CH aliphatic), 16 78 (C=O of
amide), 1609 (C=C), 1155, 1107 (SO2 two bands), 669 (Ar-H).
1H-NMR (400 MHz, CDCl3): 7.77-7.75 (d, J = 8.0 Hz, 2H, Ar-H),
7.28-7.26 (d, J = 8.0 Hz, 2H, Ar-H), 4.77-4.74 (dd,  J1  =  3.6  Hz,
J2 = 11.2 Hz, 1H), 3.49-3.41 (m, 2H), 3.40-3.38 (m, 1H), 3.34-3.29
(m, 2H),  2.40  (s,  3H),  2.09-2.03  (m,  2H),  1.89-1.81  (m,  2H),
1.27-1.24  (t,  J  =  7.12 Hz, 3H), 1.10-1.06 (t, J = 7.10 Hz, 3H),
0.89-0.87 (m, 1H). EI-MS: m/z (% rel.): 225.0 (62), 224.0 (100),
169.1 (89), 155.0 (93), 100.1 (17), 91.0 (82), 72.0 (45), 65.0 (42).
N,N-diethyl-2-methyl-1-tosylpyrrolidine-2-carboxamide
(2a2): The IR: 2949 (CH arom.), 2860 (CH aliphatic), 1713 (C=O
of amide), 1601 (C=C), 1159, 1115 (SO2  two bands), 654 (Ar-H).
1H-NMR (400 MHz, CDCl3): 7.76-7.73  (dd,  J1  =  6.0  Hz, J2 = 12.0
Hz,  2H,  Ar-H),  7.33-7.31 (d, J =  8.0  Hz,  1H,  Ar-H), 7.28-7.26
(d, J = 6.88 Hz, 1H, Ar-H), 4.73-4.70 (dd, J1  =  4.0Hz, J2 = 11.88
Hz, 1H), 4.26-4.24 (dd, J1 = 3.6 Hz, J2 = 11.88 Hz, 1H), 3.48-3.40
(d, J = 7.2 Hz, 2H), 3.34-3.23 (d, J = 7.12 Hz, 2H), 2.42 (s,  3H), 
2.39 (s,  3H),  2.13-2.03  (m,  2H),  1.96-1.71  (m,  2H), 1.26-1.23
(t, J = 7.2 Hz, 3H), 1.09-105 (t, J = 7.12 Hz, 3H).
N,N-diethyl-1-tosylpiperidine-2-carboxamide    (2b):   The
1H-NMR (400 MHz, CDCl3): 7.58-7.56 (d, J = 8.0 Hz, 2H, Ar-H),
7.21-7.19 (d, J = 8.0 Hz, 2H, Ar-H), 4.86-4.85 (m, 1H), 3.73-3.70
(q, J = 7.2 Hz, 2H), 3.31-3.26  (q,  J  =  7.08  Hz,  2H),  3.17-3.14
(m,  1H),  3.07-3.04  (m,  1H),  2.36  (s,  3H),  1.75-1.62  (m,  3H),
1.54-1.42  (m,  3H),  1.26-1.23  (t,  J  =  7.2  Hz,  3H),   0.96-0.93
(t, J = 7.08 Hz, 3H).
N,N-diethyl-2-(4-methylphenylsulfonamido) acetamide
(2c): The IR: 3034 (CH arom.), 2946 (CH aliphatic), 1707 (C=O
of amide), 1601 (C=C), 1191, 1145 (SO2 two bands), 694 (Ar-H).
1H-NMR (400 MHz, CDCl3): 7.75-7.73 (d, J = 8.0 Hz, 2H, Ar-H),
7.29-7.27 (d, J = 8.0 Hz, 2H,  Ar-H),  5.80  (s-br,  1H),  3.73-3.72
(d,  J  =  4.1  Hz,  2H),  3.30-3.25  (q,  J = 7.14 Hz, 2H), 3.17-3.11
(q, J = 7.18 Hz, 2H), 2.40 (s, 3H), 1.12-1.08 (t, J = 7.18 Hz, 3H),
1.02-0.99 (t, J = 7.14 Hz, 3H).
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N,N-diethyl-2-(4-methylphenylsulfonamido) propanamide
(2d): The IR: 3279 (NH), 3107 (CH aromatic), 1711 (C=O of
amide), 1620 (C=C), 1152, 1090 (SO2 two bands), 677 (Ar-H).
The 1H-NMR  (400  MHz,  CDCl3):  7.74-7.66  (m,  2H,   Ar-H),
7.27-7.22 (m, 2H, Ar-H), 5.46-5.44 (d, J = 8.48 Hz, 1H), 4.20-4.16
(m, 1H), 3.97-3.90 (q, J  =  7.12 Hz, 2H), 3.15-3.10 (m, 1H),  2.39
(s, 3H), 1.39-1.37 (d, J = 7.16 Hz, 3H), 1.17-1.02 (t, J = 7.12 Hz,
3H).
N,N-diethyl-3-methyl-2-(4-methylphenylsulfonamido)
butanamide (2g): The IR: 3260 (NH), 2974 (CH  arom.),  1668
(C=O of amide), 1167, 1090 (SO2 two bands), 689 (Ar-H). The
1H-NMR (400 MHz, CDCl3): 7.68-7.66 (d, J = 8.0 Hz, 2H, Ar-H),
7.23-7.21 (d, J = 8.0 Hz, 2H Ar-H), 5.78-5.75 (d, J = 9.24 Hz, 1H),
3.81-3.78 (dd, J1  = 4.22 Hz, J2  = 9.24 Hz, 1H), 3.09-3.00 (m, 4H),
2.36 (s, 3H), 1.82-1.77 (m, 1H), 1.03-1.01 (d, J = 6.8 Hz,  3H),
0.92-0.88   (t,  J = 7.2 Hz, 3H),  0.84-0.82   (d, J = 6.0 Hz, 3H),
0.84-0.81 (t, J = 6.48 Hz, 3H).
N,N-diethyl-2- (4-methylphenylsul fonamido)-3-
phenylpropanamide (2j): The IR: 3306 (NH), 2947 (CH
aliphatic), 1710 (C=O of amide), 1601 (C=C), 1213, 1171 (SO2
two  bands),  685  (Ar-H).1H-NMR (400 MHz, CDCl3): 7.63-7.61
(d, J = 8.0  Hz,  2H,  Ar-H),  7.21-7.18  (m,  5H,  Ar-H),  7.12-7.10
(d, J = 8.0 Hz, 2H, Ar-H), 5.88-5.86 (d, J = 9.48 Hz, 1H), 4.31-4.25
(m, 1H), 3.21-3.15 (m, 1H), 2.97-2.96 (m, 1H), 2.92-2.86 (m, 2H),
2.79-2.74 (q, J = 7.2 Hz, 2H), 2.37 (s, 3H), 0.88-0.84 (t, J = 7.14
Hz, 3H), 0.74-0.71 (t, J = 7.2 Hz, 3H).
Synthesis of N,N-diethyl-4-methylbenzenesulfonamide
(2d2): To a solution of diethyl amine (0.16 mL, 1.5 mmol) in
DCM (5 mL) was added sodium hydroxide (0.16 g, 4 mmol) in
water (10 mL). The mixture was stirred and maintained at a
temperature  of  -10EC,  while  a  solution  of  acid  chloride  of
1d (0.4 g, 1.5 mmol) in DCM (5 mL) was drop-wisely added
over a period of 1 h. It was warmed up to 10EC, stirred there
for 1 h and the organic layer was separated. The aqueous layer
was extracted with two 15 mL portion of DCM. The organic
layer was combined, washed with 5 mL of 5% hydrochloric
acid, two 5 mL portion of sodium bicarbonate and 5 mL of
water. The organic layer was dried over anhydrous sodium
sulfate and DCM was removed through rotary evaporator to
afford  an  oily substance (2d2). The IR: 2980 (CH aliphatic),
2876 (CH aromatic), 1632 (C=C), 1148, 1112 (SO2 two bands),
670 (Ar-H). The 1H-NMR (400 MHz, CDCl3): 7.70-7.68 (d, J = 8.0
Hz, 2H,  Ar-H),  7.29-7.27  (d,  J = 8.0  Hz, 2H,  Ar-H),  3.25-3.19
(q, J = 7.16 Hz, 4H), 2.41 (s, 3H), 1.13-1.10 (t, J =  7.16  Hz,  6H).
RESULTS AND DISCUSSION
From time to time, the development of sulfonamides is a
fascinating and informative area in medicinal chemistry. Its
functional group has a long and rich history in organic
chemistry and drug discovery38. Thus, in the continuation of
this study, effort on the sulfonamide template, the synthesis
and spectroscopic study of N,N-diethyl substituted amide
bearing p-toluene sulfonamide derivatives 2a-k in a two-step
approach starting from p-toluenesulfonyl chloride (p-TsCl)
precursor  was  reported. In  this  present  study,  p-TsCl was
not explored only as a highly economical synthon for
preparation of sulfonamide but also as pivotal skeleton for
achieving incorporation of amide within such a sulfonamide
core structure to obtain N,N-diethyl substituted amide 
bearing   p-toluene   sulfonamide   derivatives,   2a-k.  Firstly,
p-toluenesulfonyl chloride (p-TsCl) was made to react with
various amino acids under alkaline condition according to a
known procedure39 to afford a series of ten arylsulfonamides
1a-j (Fig. 1) and one tosylated sulfonamide 1k. In detail,
coupling of p-TsCl with two amino acids whose Nitrogen atom
was  secondary  amine  in  nature  afforded  the  sulfonamides
1a and 1b in excellent yields of 95.92 and 95.01%, respectively.
This reaction was carried out in aqueous sodium carbonate
and allowed to stir at room temperature for 4 h for total and
effective consumption of the amino acid (monitored with
TLC).
In similar manner, equimolar reaction of p-TsCl with eight
other amino acids containing primary amino group afforded
the corresponding sulfonamides 1c-j in good to excellent
yields (69.10-99.00%). The sulfonamides were all worked up
via the same technique irrespective of the nature of the amino
group that existed here-in. The study up was achieved by
acidifying with 2N HCl until the pH 2 was attained. The
resulting mixture was kept in freezer chest for proper
crystallization, after which it was filtered, washed with buffer
(pH 2.2) and vacuum-dried for 12 h at 60EC to obtain crude
products, which were purified using column chromatography 
with  chloroform/methanol  (9:1)  as  the  eluting  solvent.
However, tyrosine required double molar proportion of p-TsCl
for complete reaction to give 1k in 80.47% yield. The observed
crystallization of 1a-k after work-up and refrigeration was
contrary to that of "-TsCl where in crystallization could not be
achieved until lyophilization was carried out on the obtained
solution after refrigeration40. This means that "-TsCl resulted
in  highly  polar  sulfonamide,  while  p-TsCl  resulted  in  less
polar sulfonamide, which suggested that the position of
methyl/methylene group played a significant role in the polar
attribute of these type of sulfonamides. This is due to the fact
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Fig. 1: Synthesis of p-tolylsulfonamide precursors, 1a-j
Fig. 2: Mechanism for formation of 2-(4-methylphenylsulfonamido)-3-(4-(tosyloxy)phenyl)  propanoic acid, 1k
that in addition to the sulfonylation, tyrosine also experienced
tosylation on the phenolic hydroxyl group at the para position
of the phenyl ring to give 1k, whose structure was consistent
with the assigned 1H and 13C-NMR spectra (Experimental). This
unusual reaction in the formation of 1k was as a result of the
resonant stabilization of the phenolate anion conjugate base
as shown by the reaction path in Fig. 2. This resonant
stabilization caused the equilibrium to shift forward, hence,
tosylation is highly favoured.
The spectroscopic study was investigated for the
structural elucidation using FT-IR, 1H and 13C NMR, mass
spectral and elemental analytical data. The data correlated
well with the proposed structures for the synthesized
sulfonamides. Nevertheless, 1k was used as representative
compound for the spectroscopic explanation. The 1H-NMR
spectrum of 1k in deuterated chloroform showed CH3
attached  to  phenyl  and  tosylate  as  singlet  at  d  2.41  and
2.45 ppm, respectively, while the two protons of CH2-Ar
resonated as two separate doublets of doublets at d 2.97-2.92
and  3.11-3.06  ppm.  The  NH  and  its  adjacent  neighboring
CH resonated as a doublet and a quartet at d 5.14-5.12 and
4.17 and 4.12 ppm, respectively.  All  the  12  aromatic  protons
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were  experienced  as  expected  between  d  6.85-6.83  and
7.69-7.67 ppm. These chemical shifts were in concordance
with the chemical shifts of aromatic protons recently reported
by Navale et al.41 who utilized quinazoline-based framework to
prepare novel heterocyclic Schiff bases. The 13C-NMR spectrum
confirmed 1k to have twenty-three carbon atoms ranging
from d 173.7 ppm (CO) to 21.7 ppm (CH3) as envisaged. All the
eighteen aromatic carbons resonated between d 149.1 and
122.6  ppm,  while  the  three  remaining  signals  which
depicted CH3  linked  to  tosylate,  CH2 linked  to  phenyl 
(benzylic) and CH linked to NH were observed at d 21.9, 38.3
and 56.4 ppm, respectively. This was in agreement with the 
chemical shifts of aromatic carbon reported by Li et al.42 when
they developed  a   convenient   microwave-assisted  synthesis 
 of 2-substituted   quinazolin-4    (3H)-ones,    2,2-disubstituted
2,3-dihydroquinazolin-4 (1H)-ones 2 and 1H, 3H-quinazolin-
2,4-dione. The IR spectrum of 1k exhibited the absorption
bands at 1717 and 1559 cmG1 due to the presence of C=O
(acid) and C=C, respectively while SO2 functionality was
observed as two bands at 1150 and 1092 cmG1. The carbonyl
frequency herein reported (1717 cmG1) was further confirmed
by comparing it with the findings of Lewis et al.43 who
documented  the various  C=O  stretching  absorption
vibration frequencies in infrared spectra to range between
1685-1758 cmG1. Mass spectrum of 1k showed the base peak
at m/z 65.0. Although, molecular ion peak was not observed,
however, there was an appearance of a fragment m/z 443.1,
which was as a result of loss of COOH (M+-45). Other
fragmentation patterns resulted in some other prominent
daughter fragments at m/z of 171.0, 156.0, 155.0, 134.1 and
92.1 with the intensities of 35, 58, 90, 90 and 64%, respectively.
The result of elemental analysis was consistent with that of the
proposed structures showing not more than a maximum
different of +0.20 between percentage calculated and
percentage found for the carbon, hydrogen and nitrogen of
the prepared sulfonamides.
Secondly, amidation of p-tolylsulfonamide in basic
condition      gave      the      N,N-diethylamide       substituted
p-tolylsulfonamide derivatives. We were motivated to
synthesized these disubstituted amides based on the earlier
findings of Dobek et al.44 who reported that N,N-disubstituted 
thiosemicarbazones are more active than  their mono and
non-substituted   counterparts  on S. aureus  and  E. coli.  The
reaction optimization study for the amidation was
investigated using 1d as   representative p-tolylsulfonamide 
in the presence of procedure that involved either sodium 
hydroxide45 or the one that furnished the product via triethyl
amine basified condition46. The use of sodium hydroxide was
unable to deliver the  desired product 2d but rather produced
N,N-diethyl-4-methylbenzenesulfonamide  2d2.  This  was 
because nucleophilic propensity of sodium hydroxide led to
the cleavage of the S-N bond of the sulfonamide, 1d thereby
causing breaking away of amino acid part before subsequent
amidation occurred (Fig. 3a). This cleavage, which was
initiated with hydroxyl anion, resulted in temporary formation
of 4-methyl benzenesulfonic acid, which quickly reacted with
diethyl amine to afford 2d2 as shown in Fig. 3a. This was
established by the 1H-NMR of the product 2d2 obtained, which
experienced a disappearance of the signals of NH,  CH  and
CH3 protons, which were earlier present in 1d at * 8.05-8.03,
3.74-3.71 and 1.13-1.12 ppm, respectively. However, when 
triethyl amine basified condition was used, 1d was
synthetically transformed into the expected 2d in excellent
yield using one pot two steps amidation approach (Fig. 3b).
Hence, the modified Kuethe and Beutner46 method was  used
as  the  standard  optimized  condition  for  the  synthesis  of
N,N-diethyl amide substituted sulfonamides from the
corresponding p-tolylsulfonamide derivatives.
Therefore, the intermediate arylsulfonamides 1a-k
subsequently underwent one pot two steps amidation via
modification of a known procedure46 to afford the
corresponding N,N-diethyl substituted amide 2a-k (Fig. 4).
According  to  Kuethe and Beutner46, this method was good
for converting aromatic carboxylic acid, such as benzoic acid
derivatives to amide. Nevertheless, it is established as a facile
method for selective conversion of non-aromatic -COOH 
within  a  sulfonamide  to  the corresponding amide without
doing any damage to the existing -SO2NH- functionality
present. This in turn, helped us to achieve our aim of
incorporating amide group within a sulfonamide framework.
The merits of this approach include higher yields, easy study
up, shorter synthetic route because each of the crude
intermediates required no purification before taking forward,
thus, providing a quick and efficient synthetic route. The 1st
step of this method involved treatment of 1a-k with oxalyl
chloride in catalytic amount of dimethyl formamide (DMF) for
generating acid chloride instead of the common thionyl
chloride conventional approach. The chloride ion, which was
the reaction initiator and precedential species for the
formation of acid chlorides was generated by molecular
interaction between oxalyl chloride and DMF via a proposed
mechanism (Fig. 5a) similar to that of Swern oxidation47. The
in  situ   acid  chlorides  were  immediately   converted   to 
N,N-diethyl  substituted  amides 2a-k by subsequent
amidation with diethyl amine in basic medium between
controlled temperature of -10EC and room temperature.
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Fig. 4: Synthetic conversion of p-tolylsulfonamide intermediates to N,N-diethylamido-s-sulfonamides using DMF and oxalyl
chloride in triethyl amine
Moreover, compound 1a unlike other p-tolylsulfonamides,
gave two different N,N-diethylamide substituted sulfonamides
(2a and 2a2) depending on the nature of work up carried out
after the successful amidation has been completed. The
worked up of amidated product from 1a in the absence of
methanol gave N,N-diethyl-1-tosylpyrrolidine-2-carboxamide
2a while in the presence of methanol afforded N,N-diethyl-2-
methyl-1-tosylpyrrolidine-2-carboxamide 2a2 (Fig. 5b). This
additional methylation experienced in 2a2 was due to the
slight  acidic  nature  of  the  pyrrolo  proton  adjacent  to  the
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Table 1: Physicochemical parameters of the synthesized compounds
Compound code Molecular formula Mol. Wt. Yield (%) M.P. (EC) Rfb Elem. Anal. C Calcd. H (%) (Percentage of found) N
1a C12H15NO4S 269.32 95.92 41-43a 0.82 53.52 (53.68) 5.61 (5.52) 5.20 (5.19)
1b C13H17NO4S 283.35 95.01 - 0.89 55.11 (54.90) 6.05 (6.08) 4.94 (5.02)
1c C9H11NO4S 229.26 95.82 120-122 0.47 47.15 (46.90) 4.84 (5.01) 6.11 (5.97)
1d C10H13NO4S 243.28 82.57 116-118 0.78 49.37 (49.33) 5.39 (5.41) 5.76 (5.81)
1e C10H13NO4S2 275.35 88.10 161-164 0.39 43.62 (43.55) 4.68 (4.76) 5.11 (5.09)
1f C12H17NO4S2 303.40 69.10 - 0.80 47.51 (47.57) 5.69 (5.65) 4.62 (4.58)
1g C12H17NO4S 271.34 94.69 125-126 0.81 53.12 (52.91) 6.32 (6.33) 5.16 (5.08)
1h C11H15NO5S 273.31 94.42 90-92 0.62 48.34 (48.37) 5.53 (5.49) 5.12 (5.21)
1i C12H16N2O5S 300.34 82.67 145-146 0.14 47.99 (47.77) 5.37 (5.39) 9.33 (9.04)
1j C16H17NO4S 319.38 99.00 139-140 0.76 60.17 (59.97) 5.37 (5.42) 4.39 (4.36)
1k C23H23NO7S2 489.09 80.47 101-103 0.76 56.43 (56.26) 4.74 (4.79) 2.86 (3.04)
2a C16H24N2O3S 324.45 92.30 80-82 0.86 59.23 (57.97) 7.46 (7.20) 8.63 (7.92) 
2a2 C17H26N2O3S 338.47 91.70 95-96 0.89 60.33 (60.39) 7.74 (7.69) 8.28 (8.23) 
2b C17H26N2O3S 338.47 94.10 127-129 0.92 60.33 (60.37) 7.74 (7.88) 8.28 (8.34)
2c C13H20N2O3S 284.38 82.70 109-111 0.51 54.91 (54.88) 7.09 (7.11) 9.85 (9.92)
2d C14H22N2O3S 298.41 77.90 121-124 0.82 56.35 (56.41) 7.43 (7.45) 9.39 (9.34)
2d2 C11H17NO2S 227.33 81.50 188-189 0.55 58.12 (57.09 7.54 (7.47) 6.16 (6.21)
2g C16H26N2O3S 326.46 89.40 164-166 0.85 58.87 (58.83) 8.03 (8.11) 8.58 (8.55)
2j C20H26N2O3S 374.51 89.41 164-166 0.80 64.14 (64.09) 7.00 (7.03) 7.48 (7.44)
bSolvent system: CHCl3/CH3OH (9:1, v/v), Mol. Wt: Molecular weight, MP: Melting point
carbonyl group. When the amidated product from 1a was
worked up in the presence of methanol as recorded in general
procedure, methyl group replaced acidic proton found in
between  nitrogen  and  carbonyl  group  to  furnish  2a2  in
91.7% yield. This was confirmed by presence of three proton
singlet of CH3 at * 2.42 apart from that of the CH3 linked to the
phenyl group, which occurred at * 2.39. The physicochemical
parameters of the synthesized compounds were as shown in
Table 1.
CONCLUSION
A series of p-tolylsulfonamide derivatives have been
synthesized by coupling of p-TsCl with some cheap and
readily available amino acids and were subsequently brought
forward  as  intermediate  precursors  in  the  synthesis  of
selected N,N-diethyl substituted amido sulfonamides. The
methodology   discussed  in   this   study   did   not  only
provide a  new   way   to   design  and  synthesized  a  series  of
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N,N-diethylamide bearing sulfonamides in highly encouraging
yields but also demonstrated a more reliable study to achieve
such valuable intermediates which might pave way to new
series of heterocyclic compounds.
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